Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.8.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2017
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]
The components of loss before income taxes are as follows:
 
 
 
Year Ended December 31,
 
 
 
2017
 
2016
 
Domestic
 
$
(15,102,521)
 
$
(13,831,191)
 
Foreign
 
 
542,631
 
 
487,754
 
Total
 
$
(14,559,890)
 
$
(13,343,437)
 
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
The components of income tax benefit are as follows:
 
 
 
Year Ended December 31,
 
 
 
2017
 
2016
 
Deferred Taxes:
 
 
 
 
 
 
 
Federal
 
$
(1,160,312)
 
$
-
 
State
 
 
(181,661)
 
 
-
 
Total Deferred Taxes
 
$
(1,341,973)
 
$
-
 
Income Tax Benefit
 
$
(1,341,973)
 
$
-
 
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
The difference between the effective rate reflected in the provision for income taxes on loss before taxes and the amounts determined by applying the applicable statutory U.S. tax rate are analyzed below:
 
 
 
Year Ended December 31,
 
 
 
2017
 
 
2016
 
United States Federal Income Tax Rate
 
 
34.00
%
 
 
34.00
%
State Taxes, Net of Federal Benefit
 
 
4.68
%
 
 
1.84
%
Permanent Differences
 
 
(2.67)
%
 
 
(2.47)
%
Change in Valuation Allowance
 
 
46.88
%
 
 
(35.02)
%
Research and Development Credits
 
 
1.97
%
 
 
2.95
%
Tax Rate Differential
 
 
0.01
%
 
 
0.13
%
Federal Rate Change
 
 
(71.74)
%
 
 
0.00
%
Other
 
 
(3.91)
%
 
 
(1.43)
%
Effective Tax Rate
 
 
9.22
%
 
 
0.00
%
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
The Company’s deferred tax assets and liabilities consist of the following:
 
 
 
2017
 
2016
 
Net Deferred Tax Liability:
 
 
 
 
 
 
 
Net Operating Loss Carryforwards
 
$
12,624,253
 
$
18,146,381
 
Research and Development Credit Carryforwards
 
 
2,002,640
 
 
1,640,669
 
Capitalized Research and Development
 
 
5,172,541
 
 
6,398,050
 
Nonqualified Stock Option
 
 
552,096
 
 
323,832
 
Depreciation and Amortization
 
 
(82)
 
 
3,478
 
Cash Versus Accrual Adjustments
 
 
4,459,785
 
 
4,387,806
 
Total Deferred Tax Assets
 
 
24,811,233
 
 
30,900,216
 
Valuation Allowance
 
 
(24,075,539)
 
 
(30,900,216)
 
Net Deferred Tax Asset
 
 
735,694
 
 
-
 
In-Process Research and Development
 
 
(919,617)
 
 
(1,525,896)
 
Net Deferred Tax Liability
 
$
(183,923)
 
$
(1,525,896)